Skip to search formSkip to main contentSkip to account menu

Chromogranin A (344-364) fragment

Known as: catestatin, chromogranin A (344-364) 
National Institutes of Health

Related topics

Related topics

3 relations
CHGA gene

Broader (2)

Chromogranin APeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury–Induced Neointimal Hyperplasia
Abstract Catestatin, a catecholamine-release inhibitory peptide, has multiple cardiovascular activities. Conflicting results have… 
2018
2018
Catestatin serum levels are increased in male patients with obstructive sleep apnea
PurposeObstructive sleep apnea (OSA) is a complex sleep disorder associated with autonomic and sympathetic dysregulation. To the… 
2016
2016
Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia
Backgrounds Catestatin is an endogenous multifunctional neuroendocrinepeptide. Recently, catestatin was discovered as a novel… 
2014
2014
Obligatory Role for Endothelial Heparan Sulphate Proteoglycans and Caveolae Internalization in Catestatin-Dependent eNOS Activation
The chromogranin-A peptide catestatin modulates a wide range of processes, such as cardiovascular functions, innate immunity… 
2011
2011
The neuropeptide catestatin promotes vascular smooth muscle cell proliferation through the Ca2+-calcineurin-NFAT signaling pathway.
2011
2011
Catestatin is useful in detecting patients with stage B heart failure
Screening patients with stage B heart failure(HF) may be one strategy for reducing human morbidity. To describe catestatin levels… 
Highly Cited
2009
Highly Cited
2009
Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
We reported previously that chromogranin A (Chga) knockout (KO) mice are hypertensive and hyperadrenergic. Here we sought to… 
2004
2004
Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A
2000
2000
Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A352-372) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic…
1998
1998
A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)